PH
64
5
CNX
69
-4
DAL
77
-7
DIS
52
5
WDC
43
-6
ICE
56
-11
PEP
44
-3
EFX
35
-3
GILD
58
2
VFC
65
-3
MSFT
46
-11
HRB
52
-4
UAL
82
-4
K
59
6
HSIC
37
-2
C
55
-2
WMT
58
2
DFS
54
-16
NAVI
30
-8
XEL
62
14
PH
64
5
CNX
69
-4
DAL
77
-7
DIS
52
5
WDC
43
-6
ICE
56
-11
PEP
44
-3
EFX
35
-3
GILD
58
2
VFC
65
-3
MSFT
46
-11
HRB
52
-4
UAL
82
-4
K
59
6
HSIC
37
-2
C
55
-2
WMT
58
2
DFS
54
-16
NAVI
30
-8
XEL
62
14
Financhill
Back

Brainstorm Cell Therapeutics Vs. Madrigal Pharmaceuticals Industry Stock Comparison

Sell
7

BCLI
Brainstorm Cell Therapeutics

Last Price:
1.87
Seasonality Move:
2.27%
Buy
71

MDGL
Madrigal Pharmaceuticals

Last Price:
259.70
Seasonality Move:
31.67%
Sell
7
Brainstorm Cell Therapeutics (BCLI) is a Sell

Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?

  • The current Brainstorm Cell Therapeutics [BCLI] share price is $1.87. The Score for BCLI is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
  • BCLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
71
Madrigal Pharmaceuticals (MDGL) is a Buy

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BCLI Stock Price Chart

What is Brainstorm Cell Therapeutics's stock price today?

  • The Brainstorm Cell Therapeutics share price today is $1.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $259.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.

BCLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.39 Sell
Relative Strength Index (14 RSI): 30.53 Sell
Chaikin Money Flow: -6697 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.82 - 2.88) Sell
Bollinger Bands (100): (2.96 - 5.76) Sell

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 74.74 Buy
Chaikin Money Flow: 898979 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (203.29 - 223.91) Buy
Bollinger Bands (100): (221.8 - 277.54) Buy

BCLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.97 Sell
20-day SMA: 2.11 Sell
50-day SMA: 3.3 Sell
200-day SMA: 5.56 Sell
8-day EMA: 1.99 Sell
20-day EMA: 2.27 Sell
50-day EMA: 3.11 Sell
200-day EMA: 6.38 Sell

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 216.22 Buy
20-day SMA: 214.16 Buy
50-day SMA: 227.04 Buy
200-day SMA: 240.71 Buy
8-day EMA: 223.2 Buy
20-day EMA: 218.42 Buy
50-day EMA: 226.38 Buy
200-day EMA: 233.63 Buy

Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.79 per share, and an increase next year of $0.67 per share.

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.95 per share, and an increase next year of $9.71 per share.

Brainstorm Cell Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):